← Open Payments lookup

KOSSI EKLOU: Open Payments

NPI 1609360635 · MANASSAS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,892 in 64 payments from 10 companies in 2025. Trend: 2023 $514 · 2024 $1,625 · 2025 $1,892

Food & beverage: $1,892
CompanyPaymentsAmount
Alkermes, Inc.18$577
Otsuka America Pharmaceutical, Inc.7$272
E.R. Squibb & Sons, L.L.C.9$242
Janssen Pharmaceuticals, Inc6$198
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$191
ABBVIE INC.5$99
Teva Pharmaceuticals USA, Inc.4$91
Vanda Pharmaceuticals Inc.3$85
Neurocrine BioSciences, Inc.4$82
Lundbeck LLC3$54

Products named: ARISTADA, COBENFY, LYBALVI, INVEGA SUSTENNA, CAPLYTA, ABILIFY ASIMTUFII, REXULTI, VRAYLAR.

Industry payments across VA — which companies pay providers there.